R S Turpin1, C Solem2, A Pontes-Arruda3, M Sanon4, S Mehta2, F Xiaoqing Liu4, M Botteman2. 1. 1] Department of Health Delivery Systems and Pharmacoeconomics, Takeda Pharmaceuticals, Deerfield, IL, USA [2] Department of Public Policy, Thomas Jefferson University, Philadelphia, PA, USA [3] Department of Global Health Economics and Outcomes Research/Market Access, Baxter Healthcare, Deerfield, IL, USA. 2. Department of Health Economics and Outcomes Research, Pharmerit North America, Bethesda, MD, USA. 3. 1] Department of Intensive Care and Nutrition, Fernandes Tavora Hospital, Fortaleza, Brazil [2] Department of Nutrition, Christus University Center School of Medicine, Fortaleza, Brazil [3] Department of Medical Affairs, Baxter Healthcare, Asia Pacific, Shanghai, People's Republic of China. 4. Department of Global Health Economics and Outcomes Research/Market Access, Baxter Healthcare, Deerfield, IL, USA.
Abstract
BACKGROUND: Catheter-related bloodstream infections (BSIs) are a serious problem leading to increased morbidity, longer hospital stay, and hence, additional costs. This study evaluated the risk of BSI and the cost of parenteral nutrition (PN) in Germany. SUBJECTS/ METHODS: A retrospective observational chart review of patients hospitalized from October 2009 to April 2011 and receiving PN via ready-to-use three-chamber bag (MCB), single bottle (SB) or hospital compounded admixture (CPN) was conducted across Germany. Propensity score-adjusted models were used to evaluate the association between the type of PN, BSI (Cox Proportional Hazards) and hospitalization cost (generalized linear models) within a subgroup receiving all three macronutrients (lipids, amino acids, glucose). RESULTS: Of the 1995 patient records reviewed (MCB=816; CPN=584; SB=595), 1457 patients received all three macronutrients. After adjustment, SB was associated with an increased hazard of BSI, vs MCB without additions (hazard ratio (HR) (95% confidence interval (CI))=2.53 (1.66-3.86)) in the total cohort. Adding supplements to MCB on the ward also increased the BSI risk in both total and subgroup analyses. In patients receiving all three macronutrients, adjusted total costs were MCB (no additions): \[euro]6,572 (95% CI: \[euro]6,896-6263); CPN: \[euro]6,869 (\[euro]7,283-6479); SB: \[euro]6,872 (\[euro]7,242-6521); MCB (ward additions): \[euro]7,402 (\[euro]7,878-6955); P<0.001; P<0.001. CONCLUSION: Use of MCB does not appear to increase treatment costs, possibly by reducing the risk of infection. This study identified several PN preparation methods associated with a significantly increased hazard for BSI; definitive CPN findings are limited by our inability to distinguish automated from manual pharmacy compounding.
BACKGROUND: Catheter-related bloodstream infections (BSIs) are a serious problem leading to increased morbidity, longer hospital stay, and hence, additional costs. This study evaluated the risk of BSI and the cost of parenteral nutrition (PN) in Germany. SUBJECTS/ METHODS: A retrospective observational chart review of patients hospitalized from October 2009 to April 2011 and receiving PN via ready-to-use three-chamber bag (MCB), single bottle (SB) or hospital compounded admixture (CPN) was conducted across Germany. Propensity score-adjusted models were used to evaluate the association between the type of PN, BSI (Cox Proportional Hazards) and hospitalization cost (generalized linear models) within a subgroup receiving all three macronutrients (lipids, amino acids, glucose). RESULTS: Of the 1995 patient records reviewed (MCB=816; CPN=584; SB=595), 1457 patients received all three macronutrients. After adjustment, SB was associated with an increased hazard of BSI, vs MCB without additions (hazard ratio (HR) (95% confidence interval (CI))=2.53 (1.66-3.86)) in the total cohort. Adding supplements to MCB on the ward also increased the BSI risk in both total and subgroup analyses. In patients receiving all three macronutrients, adjusted total costs were MCB (no additions): \[euro]6,572 (95% CI: \[euro]6,896-6263); CPN: \[euro]6,869 (\[euro]7,283-6479); SB: \[euro]6,872 (\[euro]7,242-6521); MCB (ward additions): \[euro]7,402 (\[euro]7,878-6955); P<0.001; P<0.001. CONCLUSION: Use of MCB does not appear to increase treatment costs, possibly by reducing the risk of infection. This study identified several PN preparation methods associated with a significantly increased hazard for BSI; definitive CPN findings are limited by our inability to distinguish automated from manual pharmacy compounding.
Authors: Melinda Sawyer; Kristina Weeks; Christine A Goeschel; David A Thompson; Sean M Berenholtz; Jill A Marsteller; Lisa H Lubomski; Sara E Cosgrove; Bradford D Winters; David J Murphy; Laura C Bauer; Jordan Duval-Arnould; Julius C Pham; Elizabeth Colantuoni; Peter J Pronovost Journal: Crit Care Med Date: 2010-08 Impact factor: 7.598
Authors: Anthony T Gerlach; Sheela Thomas; Claire V Murphy; P Stanislaw P Stawicki; Melissa L Whitmill; Lydia Pourzanjani; Steven M Steinberg; Charles H Cook Journal: Surg Infect (Larchmt) Date: 2010-12-20 Impact factor: 2.150
Authors: Victor D Rosenthal; Dennis G Maki; Ajita Mehta; Carlos Alvarez-Moreno; Hakan Leblebicioglu; Francisco Higuera; Luis E Cuellar; Naoufel Madani; Zan Mitrev; Lourdes Dueñas; Josephine Anne Navoa-Ng; Humberto Guanche Garcell; Lul Raka; Rosalía Fernández Hidalgo; Eduardo A Medeiros; Souha S Kanj; Salisu Abubakar; Patricio Nercelles; Ricardo Diez Pratesi Journal: Am J Infect Control Date: 2008-10-03 Impact factor: 2.918
Authors: Victor D Rosenthal; Dennis G Maki; Camila Rodrigues; Carlos Alvarez-Moreno; Hakan Leblebicioglu; Martha Sobreyra-Oropeza; Regina Berba; Naoufel Madani; Eduardo A Medeiros; Luis E Cuéllar; Zan Mitrev; Lourdes Dueñas; Humberto Guanche-Garcell; Trudell Mapp; Souha S Kanj; Rosalía Fernández-Hidalgo Journal: Infect Control Hosp Epidemiol Date: 2010-10-28 Impact factor: 3.254